# Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

> clinical trial · VERIFIED · 2026-07-17

Status: RECRUITING · Sponsor: Priothera SAS · Condition: Adult Acute Myeloid Leukemia

- Company: Priothera SAS
- Sector: Adult Acute Myeloid Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT05429632

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.